NH

Nicholas Haft

Managing Director at OMX Ventures

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,750,000.00

Education

Lists including Nicholas

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

OMX Ventures

2020

  • Managing Director

    2020

    Life Science Focused Venture Investing.

Delix Therapeutics

2019

  • Co-Founder

    2019

Arcos Ventures

2014 - 2020

  • Managing Director

    2014 - 2020

    Investors in scientists/entrepreneurs at the forefront of biological discovery.